Location: NEW YORK, NY
CIK: 0001643354 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $16.73M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MIST | MILESTONE PHARMACEUTICALS IN | 820,000 (+8.6%) | $976K (-36.0%) | 5.8% | — | — | COM | 59935V107 |
| HUMA | HUMACYTE INC | 650,000 (+30.0%) | $394K (-17.9%) | 2.4% | — | — | COM | 44486Q103 |
| CMPS | COMPASS PATHWAYS PLC | 80,000 (+37.9%) | $442K (+10.5%) | 2.6% | — | — | SPONSORED ADS | 20451W101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 42,000 | $391K | 2.3% | — | — | — | 23954D109 |
| VTYX | VENTYX BIOSCIENCES INC | 41,500 | $375K | 2.2% | — | — | — | 92332V107 |
| NERV | MINERVA NEUROSCIENCES INC | 35,000 | $141K | 0.8% | — | — | — | 603380205 |
| — | MERSANA THERAPEUTICS INC | 100 | $2,893 | 0.0% | — | — | — | 59045L205 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JSPR | JASPER THERAPEUTICS INC | 465,000 | $407K | 2.4% | — | — | COM NEW | 471871202 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 67,500 | $1.258M | 7.5% | — | — | CLASS A ORD | 61559X104 |
| RPRX | ROYALTY PHARMA PLC | 21,400 | $1.027M | 6.1% | — | — | SHS CLASS A | G7709Q104 |
| MCRB | SERES THERAPEUTICS INC | 31,570 | $280K | 1.7% | — | — | COM NEW | 81750R201 |
| BNTC | BENITEC BIOPHARMA INC | 62,000 | $660K | 3.9% | — | — | COM NEW | 08205P209 |
| FENC | FENNEC PHARMACEUTICALS INC | 112,434 | $691K | 4.1% | — | — | COM | 31447P100 |
| CUE | CUE BIOPHARMA INC | 2,202,854 | $506K | 3.0% | — | — | COM | 22978P106 |
| RGNX | REGENXBIO INC | 26,600 | $223K | 1.3% | — | — | COM | 75901B107 |
| BHVN | BIOHAVEN LTD | 51,700 | $437K | 2.6% | — | — | COM | G1110E107 |
| IRON | DISC MEDICINE INC | 8,100 | $518K | 3.1% | — | — | COM | 254604101 |
| PRAX | PRAXIS PRECISION MEDICINES I | 4,450 | $1.434M | 8.6% | — | — | COM NEW | 74006W207 |
| AZTA | AZENTA INC | 9,700 | $205K | 1.2% | — | — | COM | 114340102 |
| QURE | UNIQURE NV | 14,700 | $240K | 1.4% | — | — | SHS | N90064101 |
| KURA | KURA ONCOLOGY INC | 46,000 | $374K | 2.2% | — | — | COM | 50127T109 |
| GERN | GERON CORP | 578,000 | $861K | 5.1% | — | — | COM | 374163103 |
| MLYS | MINERALYS THERAPEUTICS INC | 10,500 | $284K | 1.7% | — | — | COM | 603170101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 36,000 | $841K | 5.0% | — | — | COM | 87164F105 |
| EWTX | EDGEWISE THERAPEUTICS INC | 9,100 | $287K | 1.7% | — | — | COM | 28036F105 |
| LNTH | LANTHEUS HLDGS INC | 5,500 | $417K | 2.5% | — | — | COM | 516544103 |
| PCRX | PACIRA BIOSCIENCES INC | 13,500 | $305K | 1.8% | — | — | COM | 695127100 |
| IPHA | INNATE PHARMA S A | 81,151 | $104K | 0.6% | — | — | SPONSORED ADS | 45781K204 |
| VTRS | VIATRIS INC | 27,700 | $374K | 2.2% | — | — | COM | 92556V106 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 5,250 | $124K | 0.7% | — | — | COM | 03969K108 |
| INVA | INNOVIVA INC | 8,200 | $191K | 1.1% | — | — | COM | 45781M101 |
| DYN | DYNE THERAPEUTICS INC | 18,000 | $326K | 2.0% | — | — | COM | 26818M108 |
| SPRB | SPRUCE BIOSCIENCES INC | 1,000 | $65,350 | 0.4% | — | — | COM NEW | 85209E208 |
| ARDX | ARDELYX INC | 128,650 | $771K | 4.6% | — | — | COM | 039697107 |
| GHRS | GH RESEARCH PLC | 10,200 | $143K | 0.9% | — | — | ORDINARY SHARES | G3855L106 |
| BBIO | BRIDGEBIO PHARMA INC | 5,000 | $371K | 2.2% | — | — | COM | 10806X102 |
| SRPT | SAREPTA THERAPEUTICS INC | 28,500 | $620K | 3.7% | — | — | COM | 803607100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 86,000 | $308K | 1.8% | — | — | COM | 77313F106 |
| JANX | JANUX THERAPEUTICS INC | 19,000 | $264K | 1.6% | — | — | COM | 47103J105 |